Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Merck scientists present new nonsteroidal glucocorticoid receptor modulators

Oct. 21, 2004

Chiron submits Pulminiq NDA

Oct. 20, 2004

Three novel series of pyridine-based immunosuppressants developed at AstraZeneca

Oct. 14, 2004

U.K. manufacturing for Fluvirin fails to comply with GMP regulations

Oct. 11, 2004

Novartis scientists prepare and test new protein kinase C inhibitors

Oct. 11, 2004

New lipid A analogues with immunosuppressant activity discovered at Sankyo

Oct. 7, 2004

GenPat77 and MedImmune sign agreement on novel therapeutic target

Oct. 5, 2004

New immunomodulators claimed for use in viral infections and cancer

Oct. 4, 2004

Kissei scientists prepare ZAP-70 and Syk kinase inhibitors for use in immune disorders

Sep. 30, 2004

Takeda researchers discover new agonists of the bile acid-responsive receptor TGR5

Sep. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...